Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 2/3 1Phase 2 1

Status

Terminated 3Completed 3

Sponsor Class

OTHER 9INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 2Head & Neck 1

Conditions

Breast Neoplasms 12Neoplasm Metastasis 6Glioblastoma 4Triple Negative Breast Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Carcinoma, Non-Small-Cell Lung 2Treatment for Metastatic or Locally Advanced Cervical Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Pre-menopausal Breast Cancer 1Non-Small Cell Lunch Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Locally Advanced Solid Tumor 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 98Gemcitabine 70Paclitaxel 59Docetaxel 52Carboplatin 49Cisplatin 40Nivolumab 39Capecitabine 35Pemetrexed 33Fluorouracil 32Bevacizumab 32Cetuximab 31130-nm albumin-bound paclitaxel 28Trastuzumab 26Irinotecan 24Albumin-Bound Paclitaxel 24Fulvestrant 22Leucovorin 20Oxaliplatin 18Panitumumab 17abemaciclib 16Ipilimumab 16Cyclophosphamide 15cemiplimab 14atezolizumab 14Letrozole 14palbociclib 12Lapatinib 12Drug Therapy 12Doxorubicin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasm Metastasis × NVP-BKM120 × Clear all
NCT01285466 2020-12-09

A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

Novartis

Phase 1 Completed
110 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT01610284 2020-08-25

BELLE-2

Novartis

Phase 3 Completed
1,147 enrolled 20 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01633060 2019-01-30

BELLE-3

Novartis

Phase 3 Terminated
432 enrolled 20 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT01911325 2018-08-14

Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients

Novartis

Phase 1 Terminated
27 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01852292 2018-07-24

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Novartis

Phase 2 Terminated
157 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT01572727 2017-03-09

BELLE-4

Novartis

Phase 2/3 Completed
416 enrolled 11 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡